fda warning letters compounded semaglutide november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA Warns on Certain Forms

Mark Gordon

This guide aims to provide comprehensive information on whether peptides need to be refrigerated and how to properly store them for optimal research use

Key lab tests include: IGF-1: The primary marker used to assess the pituitary gland's response to sermorelin and guide dose adjustments

SEQUENCE: H-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 (trifluoroacetate salt) ONE-LETTER SEQUENCE: EGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 MOLECULAR FORMULA: C 140 H 214 N 36 O 43 MOLECULAR WEIGHT: 3089.44 STORAGE CONDITIONS: -20 5 C CAS REGISTRY NUMBER: [ 161748-29-4 ] SYNONYMS: RESEARCH AREA: Diabetes REFERENCES: Ban, K